Position in EVMN
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$5,602,663
New position
Shares Held
243,700
first reported quarter
Ownership
0.677%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026E Fund Management Co., Ltd. holds $77,672,385 across 116 Biotechnology names. EVMN ranks #2 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SMMT |
Summit Therapeutics Inc.
|
311,825 | $5,912,202 | |
| 2 | EVMN |
Evommune, Inc.
This page
|
243,700 | $5,602,663 | |
| 3 | CELC |
Celcuity Inc.
|
46,337 | $5,288,905 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,816 | $4,829,776 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,825 | $3,727,988 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
46,688 | $3,505,801 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
26,231 | $2,184,779 | |
| 8 | AVBP |
ArriVent BioPharma, Inc.
|
93,953 | $2,167,495 |
All Filings in EVMN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,602,663 | 243,700 | Shares | Sole | 2026-04-13 | |
| No filing history on record for this holder in this stock. | ||||||